0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Fibrinogen Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-29J8897
Home | Market Reports | Health| Pharmacy
Global Fibrinogen Market Outlook 2022
BUY CHAPTERS

Global Fibrinogen Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-29J8897
Report
June 2025
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Fibrinogen Market Size

In 2024, the global market size of Fibrinogen was estimated to be worth US$ 1057 million and is forecast to reach approximately US$ 2825 million by 2031 with a CAGR of 15.3% during the forecast period 2025-2031.

Fibrinogen Market

Fibrinogen Market

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.
Global core fibrinogen manufacturers include CSL Behring, LFB Group and Shanghai RAAS Blood Products etc. The top 1 companies hold a share about 52%. North America is the largest market, with a share about 31%, followed by Europe and Asia Pacific with the share about 28% and 26%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Fibrinogen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fibrinogen.
The Fibrinogen market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fibrinogen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fibrinogen manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Fibrinogen Market Report

Report Metric Details
Report Name Fibrinogen Market
Forecasted market size in 2031 approximately US$ 2825 million
CAGR 15.3%
Forecasted years 2025 - 2031
Segment by Type
  • Human Fibrinogen
  • Animal Fibrinogen
Segment by Application
  • Congenital Fibrinogen Deficiency
  • Surgical Procedures
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, GREEN CROSS, Shanghai XinXing Medical, Taibang Biologic, Octapharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Fibrinogen in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Fibrinogen manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fibrinogen sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Fibrinogen Market size in 2031?

Ans: The Fibrinogen Market size in 2031 will be approximately US$ 2825 million.

What is the market share of major companies in Fibrinogen Market?

Ans: The top 1 companies hold a share about 52%.

What is the Fibrinogen Market share by region?

Ans: North America is the largest market, with a share about 31%, followed by Europe and Asia Pacific with the share about 28% and 26%.

Who are the main players in the Fibrinogen Market report?

Ans: The main players in the Fibrinogen Market are CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, GREEN CROSS, Shanghai XinXing Medical, Taibang Biologic, Octapharma

What are the Application segmentation covered in the Fibrinogen Market report?

Ans: The Applications covered in the Fibrinogen Market report are Congenital Fibrinogen Deficiency, Surgical Procedures, Others

What are the Type segmentation covered in the Fibrinogen Market report?

Ans: The Types covered in the Fibrinogen Market report are Human Fibrinogen, Animal Fibrinogen

1 Study Coverage
1.1 Fibrinogen Product Introduction
1.2 Market by Type
1.2.1 Global Fibrinogen Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Human Fibrinogen
1.2.3 Animal Fibrinogen
1.3 Market by Application
1.3.1 Global Fibrinogen Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Congenital Fibrinogen Deficiency
1.3.3 Surgical Procedures
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Fibrinogen Market Size Estimates and Forecasts
2.1.1 Global Fibrinogen Revenue 2020-2031
2.1.2 Global Fibrinogen Sales 2020-2031
2.2 Fibrinogen Market Size by Region: 2024 Versus 2031
2.3 Fibrinogen Sales by Region (2020-2031)
2.3.1 Global Fibrinogen Sales by Region: 2020-2025
2.3.2 Global Fibrinogen Sales Forecast by Region (2026-2031)
2.3.3 Global Fibrinogen Sales Market Share by Region (2020-2031)
2.4 Fibrinogen Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Fibrinogen Revenue by Region: 2020-2025
2.4.2 Global Fibrinogen Revenue Forecast by Region (2026-2031)
2.4.3 Global Fibrinogen Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Fibrinogen Sales by Type (2020-2031)
3.1.1.1 Global Fibrinogen Sales Volume by Type (2020-2031)
3.1.1.2 Global Fibrinogen Sales Market Share by Type (2020-2031)
3.1.2 Global Fibrinogen Revenue by Type (2020-2031)
3.1.2.1 Global Fibrinogen Revenue by Type (2020-2031)
3.1.2.2 Global Fibrinogen Revenue Market Share by Type (2020-2031)
3.1.3 Fibrinogen Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Fibrinogen Sales by Application (2020-2031)
3.2.1.1 Global Fibrinogen Sales Volume by Application (2020-2031)
3.2.1.2 Global Fibrinogen Sales Market Share by Application (2020-2031)
3.2.2 Global Fibrinogen Revenue by Application (2020-2031)
3.2.2.1 Global Fibrinogen Revenue by Application (2020-2031)
3.2.2.2 Global Fibrinogen Revenue Market Share by Application (2020-2031)
3.2.3 Fibrinogen Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Human Fibrinogen of Fibrinogen Revenue Market Share by Application
3.3.2 Animal Fibrinogen of Fibrinogen Revenue Market Share by Application
4 Global Fibrinogen by Manufacturers
4.1 Global Top Fibrinogen Manufacturers by Sales (2020-2025)
4.1.1 Global Fibrinogen Sales by Manufacturer (2020-2025)
4.1.2 Global Fibrinogen Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Fibrinogen Manufacturers by Revenue (2020-2025)
4.2.1 Global Fibrinogen Revenue by Manufacturer (2020-2025)
4.2.2 Global Fibrinogen Revenue Share by Manufacturer (2020-2025)
4.3 Global Fibrinogen Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Fibrinogen Manufacturers Covered: Ranking by Revenue
4.4.2 Global Fibrinogen Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Fibrinogen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Fibrinogen Manufacturing Base Distribution, Product Type
4.5.1 Fibrinogen Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Fibrinogen Market
4.5.3 Manufacturers Fibrinogen Product Type and Application
4.5.4 Human Fibrinogen Market Sales of Fibrinogen by Manufacturer
4.5.5 Animal Fibrinogen Market Sales of Fibrinogen by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 CSL Behring
5.1.1 CSL Behring Company Information
5.1.2 CSL Behring Description, Business Overview
5.1.3 CSL Behring Fibrinogen Products Offered
5.1.4 CSL Behring Fibrinogen Sales, Revenue and Gross Margin (2020-2025)
5.1.5 CSL Behring Fibrinogen Sales by Product in 2024
5.1.6 CSL Behring Fibrinogen Sales by Application in 2024
5.1.7 CSL Behring Fibrinogen Sales by Geographic Area in 2024
5.1.8 CSL Behring Recent Developments
5.2 LFB Group
5.2.1 LFB Group Company Information
5.2.2 LFB Group Description, Business Overview
5.2.3 LFB Group Fibrinogen Products Offered
5.2.4 LFB Group Fibrinogen Sales, Revenue and Gross Margin (2020-2025)
5.2.5 LFB Group Fibrinogen Sales by Product in 2024
5.2.6 LFB Group Fibrinogen Sales by Application in 2024
5.2.7 LFB Group Fibrinogen Sales by Geographic Area in 2024
5.2.8 LFB Group Recent Developments
5.3 Shanghai RAAS Blood Products
5.3.1 Shanghai RAAS Blood Products Company Information
5.3.2 Shanghai RAAS Blood Products Description, Business Overview
5.3.3 Shanghai RAAS Blood Products Fibrinogen Products Offered
5.3.4 Shanghai RAAS Blood Products Fibrinogen Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Shanghai RAAS Blood Products Fibrinogen Sales by Product in 2024
5.3.6 Shanghai RAAS Blood Products Fibrinogen Sales by Application in 2024
5.3.7 Shanghai RAAS Blood Products Fibrinogen Sales by Geographic Area in 2024
5.3.8 Shanghai RAAS Blood Products Recent Developments
5.4 Jiangxi Boya Bio-Pharmaceutical
5.4.1 Jiangxi Boya Bio-Pharmaceutical Company Information
5.4.2 Jiangxi Boya Bio-Pharmaceutical Description, Business Overview
5.4.3 Jiangxi Boya Bio-Pharmaceutical Fibrinogen Products Offered
5.4.4 Jiangxi Boya Bio-Pharmaceutical Fibrinogen Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Jiangxi Boya Bio-Pharmaceutical Fibrinogen Sales by Product in 2024
5.4.6 Jiangxi Boya Bio-Pharmaceutical Fibrinogen Sales by Application in 2024
5.4.7 Jiangxi Boya Bio-Pharmaceutical Fibrinogen Sales by Geographic Area in 2024
5.4.8 Jiangxi Boya Bio-Pharmaceutical Recent Developments
5.5 Hualan Biological Engineering
5.5.1 Hualan Biological Engineering Company Information
5.5.2 Hualan Biological Engineering Description, Business Overview
5.5.3 Hualan Biological Engineering Fibrinogen Products Offered
5.5.4 Hualan Biological Engineering Fibrinogen Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Hualan Biological Engineering Fibrinogen Sales by Product in 2024
5.5.6 Hualan Biological Engineering Fibrinogen Sales by Application in 2024
5.5.7 Hualan Biological Engineering Fibrinogen Sales by Geographic Area in 2024
5.5.8 Hualan Biological Engineering Recent Developments
5.6 Harbin Pacific Biopharmaceutical
5.6.1 Harbin Pacific Biopharmaceutical Company Information
5.6.2 Harbin Pacific Biopharmaceutical Description, Business Overview
5.6.3 Harbin Pacific Biopharmaceutical Fibrinogen Products Offered
5.6.4 Harbin Pacific Biopharmaceutical Fibrinogen Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Harbin Pacific Biopharmaceutical Fibrinogen Sales by Product in 2024
5.6.6 Harbin Pacific Biopharmaceutical Fibrinogen Sales by Application in 2024
5.6.7 Harbin Pacific Biopharmaceutical Fibrinogen Sales by Geographic Area in 2024
5.6.8 Harbin Pacific Biopharmaceutical Recent Developments
5.7 GREEN CROSS
5.7.1 GREEN CROSS Company Information
5.7.2 GREEN CROSS Description, Business Overview
5.7.3 GREEN CROSS Fibrinogen Products Offered
5.7.4 GREEN CROSS Fibrinogen Sales, Revenue and Gross Margin (2020-2025)
5.7.5 GREEN CROSS Fibrinogen Sales by Product in 2024
5.7.6 GREEN CROSS Fibrinogen Sales by Application in 2024
5.7.7 GREEN CROSS Fibrinogen Sales by Geographic Area in 2024
5.7.8 GREEN CROSS Recent Developments
5.8 Shanghai XinXing Medical
5.8.1 Shanghai XinXing Medical Company Information
5.8.2 Shanghai XinXing Medical Description, Business Overview
5.8.3 Shanghai XinXing Medical Fibrinogen Products Offered
5.8.4 Shanghai XinXing Medical Fibrinogen Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Shanghai XinXing Medical Fibrinogen Sales by Product in 2024
5.8.6 Shanghai XinXing Medical Fibrinogen Sales by Application in 2024
5.8.7 Shanghai XinXing Medical Fibrinogen Sales by Geographic Area in 2024
5.8.8 Shanghai XinXing Medical Recent Developments
5.9 Taibang Biologic
5.9.1 Taibang Biologic Company Information
5.9.2 Taibang Biologic Description, Business Overview
5.9.3 Taibang Biologic Fibrinogen Products Offered
5.9.4 Taibang Biologic Fibrinogen Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Taibang Biologic Fibrinogen Sales by Product in 2024
5.9.6 Taibang Biologic Fibrinogen Sales by Application in 2024
5.9.7 Taibang Biologic Fibrinogen Sales by Geographic Area in 2024
5.9.8 Taibang Biologic Recent Developments
5.10 Octapharma
5.10.1 Octapharma Company Information
5.10.2 Octapharma Description, Business Overview
5.10.3 Octapharma Fibrinogen Products Offered
5.10.4 Octapharma Fibrinogen Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Octapharma Fibrinogen Sales by Product in 2024
5.10.6 Octapharma Fibrinogen Sales by Application in 2024
5.10.7 Octapharma Fibrinogen Sales by Geographic Area in 2024
5.10.8 Octapharma Recent Developments
6 North America
6.1 North America Fibrinogen Market Size YoY Growth 2020-2031
6.2 North America Fibrinogen Market Facts & Figures by Country
6.2.1 North America Fibrinogen Sales by Country (2020-2031)
6.2.2 North America Fibrinogen Revenue by Country (2020-2031)
6.3 North America Fibrinogen Sales by Type (2020-2025)
6.4 North America Fibrinogen Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Fibrinogen Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Fibrinogen Market Facts & Figures by Region
7.2.1 Asia-Pacific Fibrinogen Sales by Region (2020-2031)
7.2.2 Asia-Pacific Fibrinogen Revenue by Region (2020-2031)
7.3 Asia-Pacific Fibrinogen Sales by Type (2020-2025)
7.4 Asia-Pacific Fibrinogen Sales by Application (2020-2025)
8 Europe
8.1 Europe Fibrinogen Market Size YoY Growth 2020-2031
8.2 Europe Fibrinogen Market Facts & Figures by Country
8.2.1 Europe Fibrinogen Sales by Country (2020-2031)
8.2.2 Europe Fibrinogen Revenue by Country (2020-2031)
8.3 Europe Fibrinogen Sales by Type (2020-2025)
8.4 Europe Fibrinogen Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Fibrinogen Market Size YoY Growth 2020-2031
9.2 Latin America Fibrinogen Market Facts & Figures by Country
9.2.1 Latin America Fibrinogen Sales by Country (2020-2031)
9.2.2 Latin America Fibrinogen Revenue by Country (2020-2031)
9.3 Latin America Fibrinogen Sales by Type (2020-2025)
9.4 Latin America Fibrinogen Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Fibrinogen Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Fibrinogen Market Facts & Figures by Country
10.2.1 Middle East and Africa Fibrinogen Sales by Country (2020-2031)
10.2.2 Middle East and Africa Fibrinogen Revenue by Country (2020-2031)
10.3 Middle East and Africa Fibrinogen Sales by Type (2020-2025)
10.4 Middle East and Africa Fibrinogen Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Fibrinogen Supply Chain Analysis
11.2 Fibrinogen Key Raw Materials and Upstream Suppliers
11.3 Fibrinogen Clients Analysis
11.4 Fibrinogen Sales Channel and Sales Model Analysis
11.4.1 Fibrinogen Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Fibrinogen Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Fibrinogen Distributors
12 Fibrinogen Market Dynamics
12.1 Fibrinogen Industry Trends
12.2 Fibrinogen Market Drivers
12.3 Fibrinogen Market Challenges
12.4 Fibrinogen Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
 Table 1. Global Fibrinogen Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Fibrinogen Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Fibrinogen Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Fibrinogen Sales by Region (2020-2025) & (Kg)
 Table 5. Global Fibrinogen Sales Forecast by Region (2026-2031) & (Kg)
 Table 6. Global Fibrinogen Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Fibrinogen Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Fibrinogen Sales Volume by Type (2020-2025) & (Kg)
 Table 9. Global Fibrinogen Sales Volume by Type (2026-2031) & (Kg)
 Table 10. Global Fibrinogen Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Fibrinogen Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Fibrinogen Sales Volume by Application (2020-2025) & (Kg)
 Table 13. Global Fibrinogen Sales Volume by Application (2026-2031) & (Kg)
 Table 14. Global Fibrinogen Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Fibrinogen Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Fibrinogen Sales by Manufacturer (2020-2025) & (Kg)
 Table 17. Global Fibrinogen Sales Share by Manufacturer (2020-2025)
 Table 18. Fibrinogen Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Fibrinogen Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Fibrinogen Price (2020-2025) & (US$/g)
 Table 21. Ranking of Global Top Fibrinogen Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Fibrinogen Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Fibrinogen by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibrinogen as of 2024)
 Table 24. Fibrinogen Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Fibrinogen Market
 Table 26. Manufacturers Fibrinogen Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. CSL Behring Company Information
 Table 29. CSL Behring Description and Business Overview
 Table 30. CSL Behring Fibrinogen Product
 Table 31. CSL Behring Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 32. CSL Behring Sales Proportion of Fibrinogen by Product in 2024
 Table 33. CSL Behring Sales Proportion of Fibrinogen by Application in 2024
 Table 34. CSL Behring Sales Proportion of Fibrinogen by Geographic Area in 2024
 Table 35. CSL Behring Recent Developments
 Table 36. LFB Group Company Information
 Table 37. LFB Group Description and Business Overview
 Table 38. LFB Group Fibrinogen Product
 Table 39. LFB Group Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 40. LFB Group Sales Proportion of Fibrinogen by Product in 2024
 Table 41. LFB Group Sales Proportion of Fibrinogen by Application in 2024
 Table 42. LFB Group Sales Proportion of Fibrinogen by Geographic Area in 2024
 Table 43. LFB Group Recent Developments
 Table 44. Shanghai RAAS Blood Products Company Information
 Table 45. Shanghai RAAS Blood Products Description and Business Overview
 Table 46. Shanghai RAAS Blood Products Fibrinogen Product
 Table 47. Shanghai RAAS Blood Products Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 48. Shanghai RAAS Blood Products Sales Proportion of Fibrinogen by Product in 2024
 Table 49. Shanghai RAAS Blood Products Sales Proportion of Fibrinogen by Application in 2024
 Table 50. Shanghai RAAS Blood Products Sales Proportion of Fibrinogen by Geographic Area in 2024
 Table 51. Shanghai RAAS Blood Products Recent Developments
 Table 52. Jiangxi Boya Bio-Pharmaceutical Company Information
 Table 53. Jiangxi Boya Bio-Pharmaceutical Description and Business Overview
 Table 54. Jiangxi Boya Bio-Pharmaceutical Fibrinogen Product
 Table 55. Jiangxi Boya Bio-Pharmaceutical Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 56. Jiangxi Boya Bio-Pharmaceutical Sales Proportion of Fibrinogen by Product in 2024
 Table 57. Jiangxi Boya Bio-Pharmaceutical Sales Proportion of Fibrinogen by Application in 2024
 Table 58. Jiangxi Boya Bio-Pharmaceutical Sales Proportion of Fibrinogen by Geographic Area in 2024
 Table 59. Jiangxi Boya Bio-Pharmaceutical Recent Developments
 Table 60. Hualan Biological Engineering Company Information
 Table 61. Hualan Biological Engineering Description and Business Overview
 Table 62. Hualan Biological Engineering Fibrinogen Product
 Table 63. Hualan Biological Engineering Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 64. Hualan Biological Engineering Sales Proportion of Fibrinogen by Product in 2024
 Table 65. Hualan Biological Engineering Sales Proportion of Fibrinogen by Application in 2024
 Table 66. Hualan Biological Engineering Sales Proportion of Fibrinogen by Geographic Area in 2024
 Table 67. Hualan Biological Engineering Recent Developments
 Table 68. Harbin Pacific Biopharmaceutical Company Information
 Table 69. Harbin Pacific Biopharmaceutical Description and Business Overview
 Table 70. Harbin Pacific Biopharmaceutical Fibrinogen Product
 Table 71. Harbin Pacific Biopharmaceutical Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 72. Harbin Pacific Biopharmaceutical Sales Proportion of Fibrinogen by Product in 2024
 Table 73. Harbin Pacific Biopharmaceutical Sales Proportion of Fibrinogen by Application in 2024
 Table 74. Harbin Pacific Biopharmaceutical Sales Proportion of Fibrinogen by Geographic Area in 2024
 Table 75. Harbin Pacific Biopharmaceutical Recent Developments
 Table 76. GREEN CROSS Company Information
 Table 77. GREEN CROSS Description and Business Overview
 Table 78. GREEN CROSS Fibrinogen Product
 Table 79. GREEN CROSS Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 80. GREEN CROSS Sales Proportion of Fibrinogen by Product in 2024
 Table 81. GREEN CROSS Sales Proportion of Fibrinogen by Application in 2024
 Table 82. GREEN CROSS Sales Proportion of Fibrinogen by Geographic Area in 2024
 Table 83. GREEN CROSS Recent Developments
 Table 84. Shanghai XinXing Medical Company Information
 Table 85. Shanghai XinXing Medical Description and Business Overview
 Table 86. Shanghai XinXing Medical Fibrinogen Product
 Table 87. Shanghai XinXing Medical Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 88. Shanghai XinXing Medical Sales Proportion of Fibrinogen by Product in 2024
 Table 89. Shanghai XinXing Medical Sales Proportion of Fibrinogen by Application in 2024
 Table 90. Shanghai XinXing Medical Sales Proportion of Fibrinogen by Geographic Area in 2024
 Table 91. Shanghai XinXing Medical Recent Developments
 Table 92. Taibang Biologic Company Information
 Table 93. Taibang Biologic Description and Business Overview
 Table 94. Taibang Biologic Fibrinogen Product
 Table 95. Taibang Biologic Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 96. Taibang Biologic Sales Proportion of Fibrinogen by Product in 2024
 Table 97. Taibang Biologic Sales Proportion of Fibrinogen by Application in 2024
 Table 98. Taibang Biologic Sales Proportion of Fibrinogen by Geographic Area in 2024
 Table 99. Taibang Biologic Recent Developments
 Table 100. Octapharma Company Information
 Table 101. Octapharma Description and Business Overview
 Table 102. Octapharma Fibrinogen Product
 Table 103. Octapharma Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 104. Octapharma Sales Proportion of Fibrinogen by Product in 2024
 Table 105. Octapharma Sales Proportion of Fibrinogen by Application in 2024
 Table 106. Octapharma Sales Proportion of Fibrinogen by Geographic Area in 2024
 Table 107. Octapharma Recent Developments
 Table 108. North America Fibrinogen Sales by Country (2020-2025) & (Kg)
 Table 109. North America Fibrinogen Sales by Country (2026-2031) & (Kg)
 Table 110. North America Fibrinogen Revenue by Country (2020-2025) & (US$ Million)
 Table 111. North America Fibrinogen Revenue by Country (2026-2031) & (US$ Million)
 Table 112. North America Fibrinogen Sales by Type (2020-2025) & (Kg)
 Table 113. North America Fibrinogen Sales by Application (2020-2025) & (Kg)
 Table 114. Asia-Pacific Fibrinogen Sales by Region (2020-2025) & (Kg)
 Table 115. Asia-Pacific Fibrinogen Sales by Region (2026-2031) & (Kg)
 Table 116. Asia-Pacific Fibrinogen Revenue by Region (2020-2025) & (US$ Million)
 Table 117. Asia-Pacific Fibrinogen Revenue by Region (2026-2031) & (US$ Million)
 Table 118. Asia-Pacific Fibrinogen Sales by Type (2020-2025) & (Kg)
 Table 119. Asia-Pacific Fibrinogen Sales by Application (2020-2025) & (Kg)
 Table 120. Europe Fibrinogen Sales by Country (2020-2025) & (Kg)
 Table 121. Europe Fibrinogen Sales by Country (2026-2031) & (Kg)
 Table 122. Europe Fibrinogen Revenue by Country (2020-2025) & (US$ Million)
 Table 123. Europe Fibrinogen Revenue by Country (2026-2031) & (US$ Million)
 Table 124. Europe Fibrinogen Sales by Type (2020-2025) & (Kg)
 Table 125. Europe Fibrinogen Sales by Application (2020-2025) & (Kg)
 Table 126. Latin America Fibrinogen Sales by Country (2020-2025) & (Kg)
 Table 127. Latin America Fibrinogen Sales by Country (2026-2031) & (Kg)
 Table 128. Latin America Fibrinogen Revenue by Country (2020-2025) & (US$ Million)
 Table 129. Latin America Fibrinogen Revenue by Country (2026-2031) & (US$ Million)
 Table 130. Latin America Fibrinogen Sales by Type (2020-2025) & (Kg)
 Table 131. Latin America Fibrinogen Sales by Application (2020-2025) & (Kg)
 Table 132. Middle East and Africa Fibrinogen Sales by Country (2020-2025) & (Kg)
 Table 133. Middle East and Africa Fibrinogen Sales by Country (2026-2031) & (Kg)
 Table 134. Middle East and Africa Fibrinogen Revenue by Country (2020-2025) & (US$ Million)
 Table 135. Middle East and Africa Fibrinogen Revenue by Country (2026-2031) & (US$ Million)
 Table 136. Middle East and Africa Fibrinogen Sales by Type (2020-2025) & (Kg)
 Table 137. Middle East and Africa Fibrinogen Sales by Application (2020-2025) & (Kg)
 Table 138. Fibrinogen Key Raw Materials, Industry Status and Trend
 Table 139. Fibrinogen Key Raw Materials and Upstream Suppliers
 Table 140. Fibrinogen Clients Status and Trend
 Table 141. Fibrinogen Typical Clients
 Table 142. Fibrinogen Distributors
 Table 143. Fibrinogen Market Trends
 Table 144. Fibrinogen Market Drivers
 Table 145. Fibrinogen Market Challenges
 Table 146. Fibrinogen Market Restraints
 Table 147. Research Programs/Design for This Report
 Table 148. Key Data Information from Secondary Sources
 Table 149. Key Data Information from Primary Sources
 Table 150. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Fibrinogen Product Picture
 Figure 2. Global Fibrinogen Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Fibrinogen Sales Market Share by Type in 2024 & 2031
 Figure 4. Human Fibrinogen Product Picture
 Figure 5. Animal Fibrinogen Product Picture
 Figure 6. Global Fibrinogen Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Fibrinogen Sales Market Share by Application in 2024 & 2031
 Figure 8. Congenital Fibrinogen Deficiency
 Figure 9. Surgical Procedures
 Figure 10. Others
 Figure 11. Fibrinogen Report Years Considered
 Figure 12. Global Fibrinogen Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Fibrinogen Market Size 2020-2031 (US$ Million)
 Figure 14. Global Fibrinogen Sales 2020-2031 (Kg)
 Figure 15. Global Fibrinogen Sales Market Share Forecast by Region (2020-2031)
 Figure 16. Global Fibrinogen Revenue Market Share by Region (2020-2031)
 Figure 17. Global Fibrinogen Sales Market Share Forecast by Type (2020-2031)
 Figure 18. Global Fibrinogen Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. Fibrinogen Average Selling Price (ASP) by Type (2020-2025) & (US$/g)
 Figure 20. Global Fibrinogen Sales Market Share Forecast by Application (2020-2031)
 Figure 21. Global Fibrinogen Revenue Market Share Forecast by Application (2020-2031)
 Figure 22. Fibrinogen Average Selling Price (ASP) by Application (2020-2025) & (US$/g)
 Figure 23. Human Fibrinogen of Fibrinogen Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Animal Fibrinogen of Fibrinogen Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Global Fibrinogen Sales Share by Manufacturer in 2024
 Figure 26. Fibrinogen Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 27. Human Fibrinogen Market Sales Proportion by Manufacturer in 2024
 Figure 28. Animal Fibrinogen Market Sales Proportion by Manufacturer in 2024
 Figure 29. North America Fibrinogen Revenue 2020-2031 (US$ Million)
 Figure 30. North America Fibrinogen Sales Market Share by Type (2020-2025)
 Figure 31. North America Fibrinogen Sales Market Share by Application (2020-2025)
 Figure 32. Asia-Pacific Fibrinogen Revenue 2020-2031 (US$ Million)
 Figure 33. Asia-Pacific Fibrinogen Sales Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific Fibrinogen Revenue Market Share by Region (2020-2031)
 Figure 35. Asia-Pacific Fibrinogen Sales Market Share by Type (2020-2025)
 Figure 36. Asia-Pacific Fibrinogen Sales Market Share by Application (2020-2025)
 Figure 37. Europe Fibrinogen Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Europe Fibrinogen Sales Market Share by Country (2020-2031)
 Figure 39. Europe Fibrinogen Revenue Market Share by Country (2020-2031)
 Figure 40. Europe Fibrinogen Sales Market Share by Type (2020-2025)
 Figure 41. Europe Fibrinogen Sales Market Share by Application (2020-2025)
 Figure 42. Latin America Fibrinogen Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 43. Latin America Fibrinogen Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Fibrinogen Revenue Market Share by Country (2020-2025)
 Figure 45. Latin America Fibrinogen Sales Market Share by Type (2020-2025)
 Figure 46. Latin America Fibrinogen Sales Market Share by Application (2020-2025)
 Figure 47. Middle East and Africa Fibrinogen Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 48. Middle East and Africa Fibrinogen Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Fibrinogen Revenue Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Fibrinogen Sales Market Share by Type (2020-2025)
 Figure 51. Middle East and Africa Fibrinogen Sales Market Share by Application (2020-2025)
 Figure 52. Fibrinogen Supply Chain (Upstream and Downstream Market)
 Figure 53. Global Production Market Share of Fibrinogen Raw Materials by Region in 2024
 Figure 54. Fibrinogen Distribution Channels
 Figure 55. Global Fibrinogen Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 56. Global Fibrinogen Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart